Showing results (131-140 of 232) with videos related to

Sort By:
Pageof 24
Diabetes/Metabolism Research and Reviews|January 30, 2019
Antibodies to oxidized insulin improve prediction of type 1 diabetes in children with positive standard islet autoantibodiesRocky Strollo, Chiara Vinci, Nicola Napoli, et al.
Cell Transplantation|September 15, 2006
Suppression of human T-cell responses to beta-cells by activation of B7-H4 pathwayDawei Ou, Xiaojie Wang, Daniel L Metzger, et al.
Diabetes Care|December 7, 2007
The protein tyrosine phosphatase nonreceptor 22 (PTPN22) is associated with high GAD antibody titer in latent autoimmune diabetes in adults: Non Insulin Requiring Autoimmune Diabetes (NIRAD) Study 3Antonio Petrone, Concetta Suraci, Marco Capizzi, et al.
Scientific Reports|November 4, 2017
Proof-of-concept Raman spectroscopy study aimed to differentiate thyroid follicular patterned lesionsJulietta V Rau, Marco Fosca, Valerio Graziani, et al.
Cell Transplantation|September 6, 2017
Suppression of Human T-Cell Responses to β-Cells by Activation of B7-H4 PathwayDawei Ou, Xiaojie Wang, Daniel L Metzger, et al.
The Journal of Clinical Endocrinology and Metabolism|February 20, 2021
Laser Ablation Versus Radiofrequency Ablation for Thyroid Nodules: 12-Month Results of a Randomized Trial (LARA II Study)Roberto Cesareo, Silvia Manfrini, Valerio Pasqualini, et al.
Immunogenetics|August 20, 2002
Association of CTLA-4 variation with type I diabetes in FilipinosWilliam Klitz, Teodorica L Bugawan, Araceli Panelo, et al.
Journal of Endocrinological Investigation|May 27, 2014
Osteocalcin levels are inversely associated with Hba1c and BMI in adult subjects with long-standing type 1 diabetesErnesto Maddaloni, Luca D'Onofrio, Angelo Lauria, et al.
Diabetes/Metabolism Research and Reviews|February 15, 2008
Westernization of the Filipino population resident in Rome: obesity, diabetes and hypertensionUmberto Vespasiani Gentilucci, Antonio Picardi, Silvia Manfrini, et al.
BMC Endocrine Disorders|January 10, 2015
Insulin secretion in patients with latent autoimmune diabetes (LADA): half way between type 1 and type 2 diabetes: action LADA 9Marta Hernandez, Angels Mollo, Josep Ramon Marsal, et al.
Pageof 24